Cardiac Transplantation and Mechanical Circulatory Support in Amyloidosis
- PMID: 34729523
- PMCID: PMC8543081
- DOI: 10.1016/j.jaccao.2021.05.007
Cardiac Transplantation and Mechanical Circulatory Support in Amyloidosis
Keywords: AL, light chain subtype; ASCT, autologous stem cell transplantation; ATTR-v, variant (hereditary) transthyretin subtype; ATTR-wt, wild-type transthyretin subtype; MCS, mechanical circulatory support; amyloidosis; heart failure; treatment.
Conflict of interest statement
Dr Witteles has served on advisory boards for Pfizer, Alnylam, Eidos, Ionis/Akcea, and Regeneron.
Figures


Similar articles
-
Tafamidis: a selective transthyretin stabilizer to treat wild-type ATTR amyloidosis and hereditary ATTR amyloidosis with cardiomyopathy.Drugs Today (Barc). 2019 Dec;55(12):727-734. doi: 10.1358/dot.2019.55.12.3078389. Drugs Today (Barc). 2019. PMID: 31942875
-
Cardiac amyloidosis: updates in diagnosis and management.Arch Cardiovasc Dis. 2013 Oct;106(10):528-40. doi: 10.1016/j.acvd.2013.06.051. Epub 2013 Sep 23. Arch Cardiovasc Dis. 2013. PMID: 24070600 Review.
-
State-of-the-art review on management of end-stage heart failure in amyloidosis: transplant and beyond.Heart Fail Rev. 2022 Sep;27(5):1567-1578. doi: 10.1007/s10741-021-10209-3. Epub 2022 Feb 3. Heart Fail Rev. 2022. PMID: 35112265 Review.
-
Evidence of Concurrent Light Chain and Transthyretin Cardiac Amyloidosis in 2 Patients.JACC CardioOncol. 2020 Mar 17;2(1):127-130. doi: 10.1016/j.jaccao.2020.01.001. eCollection 2020 Mar. JACC CardioOncol. 2020. PMID: 34396218 Free PMC article. Review. No abstract available.
-
Diagnosis and treatment of heart failure in hereditary transthyretin amyloidosis.Clin Auton Res. 2019 Sep;29(Suppl 1):45-53. doi: 10.1007/s10286-019-00629-5. Epub 2019 Aug 26. Clin Auton Res. 2019. PMID: 31452023 Free PMC article. Review.
Cited by
-
Transthyretin cardiac amyloidosis: advances and ambiguities.Heart Fail Rev. 2025 Aug 29. doi: 10.1007/s10741-025-10552-9. Online ahead of print. Heart Fail Rev. 2025. PMID: 40877718 Review.
-
Heart Transplant and Durable Mechanical Circulatory Support for Specific Less-Common Cardiomyopathies.CJC Open. 2025 Mar 24;7(6):813-820. doi: 10.1016/j.cjco.2025.03.015. eCollection 2025 Jun. CJC Open. 2025. PMID: 40586021 Free PMC article. Review.
-
Heart Failure Management in Cardiac Amyloidosis: Towards a Paradigm Shift.Card Fail Rev. 2025 Jul 17;11:e15. doi: 10.15420/cfr.2024.33. eCollection 2025. Card Fail Rev. 2025. PMID: 40741341 Free PMC article. Review.
-
A review of recent advances in the diagnosis of cardiac amyloidosis, treatment of its cardiac complications, and disease-modifying therapies.F1000Res. 2023 Feb 20;12:192. doi: 10.12688/f1000research.130285.1. eCollection 2023. F1000Res. 2023. PMID: 36911240 Free PMC article. Review.
-
The importance of pathways to facilitate early diagnosis and treatment of patients with cardiac amyloidosis.Ther Adv Cardiovasc Dis. 2023 Jan-Dec;17:17539447231216318. doi: 10.1177/17539447231216318. Ther Adv Cardiovasc Dis. 2023. PMID: 38099406 Free PMC article. Review.
References
-
- Dubrey S.W., Burke M.M., Hawkins P.N., Banner N.R. Cardiac transplantation for amyloid heart disease: the United Kingdom experience. J Heart Lung Transplant. 2004;23:1142–1153. - PubMed
-
- Kpodonu J., Massad M.G., Caines A., Geha A.S. Outcome of heart transplantation in patients with amyloid cardiomyopathy. J Heart Lung Transplant. 2005;24:1763–1765. - PubMed
-
- Roig E., Almenar L., Gonzalez-Vilchez F. Outcomes of heart transplantation for cardiac amyloidosis: subanalysis of the Spanish registry for heart transplantation. Am J Transplant. 2009;9:1414–1419. - PubMed
-
- Kristen A.V., Kreusser M.M., Blum P. Improved outcomes after heart transplantation for cardiac amyloidosis in the modern era. J Heart Lung Transplant. 2018;37:611–618. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous